TOENAIL FUNGUS TREATMENT MAXIMUM STRENGTH Liquid

Manufacturer
Shenzhen Ctrip Technology Co., Ltd.
Effective date
2026-01-19
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:33:43

Label at a glance#

ProductTOENAIL FUNGUS TREATMENT MAXIMUM STRENGTH Liquid
Active ingredientTOLNAFTATE
Label structure13 sections

Storage and handling

SHAKE WELL BEFORE USE Store at room temperature 5--30°C(41°-86°F), Please store in a cool,dry place away from direct sunlight. Keep tightly closed when not in use

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

TOENAIL FUNGUS TREATMENT MAXIMUM STRENGTH Liquid

OTC - ACTIVE INGREDIENT SECTION

Tolnaftate 1%

OTC - PURPOSE SECTION

Anti-fungal and Nail Renewal

INDICATIONS & USAGE SECTION

Antifungal use on fingemails, toenails, and the immediately adjacent skin.
Fungal nails, Athlete's Foot, Tinea Manuum, Ringwomcaused byfungus and bacterial infection.
For all caused by nail fungus, nail discoloration, nail thickening,nailsplitting, nail crumbling

WARNINGS SECTION

Keep away from fire and flame.
Keep out of reach of children.
For use on nails and the immediately adjacent skin only.

OTC - DO NOT USE SECTION

If a reaction suggesting sensitivity or iritation occurs.

OTC - WHEN USING SECTION

Not for ophthalmic, oral, or intravaginal use

OTC - STOP USE SECTION

lf the area of application shows signs of increased iritation.
There is no improvement within 8 weeks.
When Pregnant or breast-feeding

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If accidental ingestion occurs, seek medical assistance or contact a Poison Control Center immediately.

DOSAGE & ADMINISTRATION SECTION

Use once daily, preferably before bedtimeUnscrew the cap and tilt the bottle to apply the medicine directly to thenail. The medication will then penetrate deeply into the nail.If the nail area is infected, spray the medication onto the affected toearea.

STORAGE AND HANDLING SECTION

SHAKE WELL BEFORE USE
Store at room temperature 5--30°C(41°-86°F), Please store in a cool,dry place away from direct sunlight.
Keep tightly closed when not in use

INACTIVE INGREDIENT SECTION

UNDECYLENIC ACID
ALCOHOL
DIMETHICONE
C12-15 ALKYL LACTATE
ETHYLHEXYLGLYCERIN
TOCOPHEROL
EDETATE DISODIUM
PHENOXYETHANOL
WATER

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
313423tolnaftate 1 % Topical SolutionPSN2
313423tolnaftate 10 MG/ML Topical SolutionSCD2
313423tolnaftate 1 % Topical SolutionSY2

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84614-002-01TOENAIL FUNGUS TREATMENT MAXIMUM STRENGTH Liquid2 in 1 PACKAGELIQUID22
84614-002-01TOENAIL FUNGUS TREATMENT MAXIMUM STRENGTH Liquid30 mL in 1 BOTTLELIQUID302

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84614-00284614-002-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TOENAIL FUNGUS TREATMENT MAXIMUM STRENGTH LiquidTOLNAFTATEShenzhen Ctrip Technology Co., Ltd.1fb03184-5f21-c82a-e063-6294a90a9fa42026-01-19WarningsExact identifier
ndc (package): 84614-002-01
ndc (product): 84614-002
ndc11 (package): 84614000201
spl id: 48b9ae23-4075-7b2c-e063-6294a90a27e6
spl set id: 1fb03184-5f21-c82a-e063-6294a90a9fa4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.